Trisha Michel Wise-Draper MD PhD
Head & Neck Cancer
Associate Professor of Medicine, Director of Medical Oncology Services, Medical Director UCCC Clinical Trials Office
Join to View Full Profile
234 Goodman StMl 0781Cincinnati, OH 45219
Phone+1 513-584-4505
Dr. Wise-Draper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2013- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2011
University of Cincinnati College of MedicineClass of 2010
Certifications & Licensure
IN State Medical License 2026 - 2027
OH State Medical License 2010 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
- Study of Letrozole in Recurrent Gliomas Start of enrollment: 2017 May 16
- Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy Start of enrollment: 2017 Dec 06
Publications & Presentations
PubMed
- Optimization of head and neck cancer peripheral blood mononuclear cell processing for robust downstream functional immune analysis.Margaret Nelson, Katelyn Jansen, Farah Sagin, Maria Lehn, Hani Alrefai
Medrxiv. 2026-04-30 - Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial.Glenn J Hanna, Olga Y Zamulko, Punita Grover, Douglas R Adkins, Peter J Oppelt
JAMA Otolaryngology-- Head & Neck Surgery. 2026-04-01 - Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience.Luana G Sousa, James Edward Bates, Payal Anand, Jimmy J Caudell, A Dimitrios Colevas
Journal of the National Cancer Institute. 2026-04-01
Press Mentions
HMN 2025: How Combination Immunotherapy Helps Overcome Melanoma Treatment ResistanceNovember 15th, 2025- Combination Immunotherapy Breaks Through Melanoma Treatment ResistanceNovember 7th, 2025
- University of Cincinnati Cancer Center Announces Breakthrough in Melanoma Treatment with Oncolytic Virus and Immunotherapy ComboNovember 7th, 2025
Grant Support
- Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacyUNIVERSITY OF CINCINNATI2022–2027
- Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacyUNIVERSITY OF CINCINNATI2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
